Meet Ankit Patel, QuantiGene™ Assay Developer at Thermo Fisher Scientific

Plus: 6 tips for QuantiGene assays When you want an assay that can detect nucleic acids, you’ll likely choose the high-quality Invitrogen™ ProcartaPlex™ and QuantiGene™ Plex assays from Thermo Fisher Scientific, a Luminex partner. The QuantiGene assay uses branched DNA (bDNA) technology, relying on signal amplification instead of target amplification for optimal quantitation of transcripts. […]

Read More…

Querying RAS: How a Multiplex Assay Became a Robust Transcriptional Readout for HTS

In Q&A, scientists describe development and offer multiplexing tips A few years ago, scientists at Merck & Co were looking for a better way to evaluate the activity of the RAS-MAPK pathway, which is particularly important for cancer development and can also signal susceptibility or resistance to emerging therapies. They used the Thermo Fisher QuantiGene™ […]

Read More…

xMAP®-powered Assay Provides Critical Clues from Liquid Biopsy Samples

14-gene assay interrogates circulating tumor cells Liquid biopsies are opening new avenues for cancer research and diagnosis, but even experts in the field continue to nail down the best protocols for analyzing the cell-free DNA and circulating tumor cells (CTCs) contained in these peripheral blood samples. Evi Lianidou, professor of Analytical Chemistry and Clinical Chemistry […]

Read More…

Five Things We Learned from an xMAP® Power User

DKFZ’s Tim Waterboer has published more xMAP papers than any other user At the fourth annual xMAP® Connect user group meeting held in Amsterdam late last year, we had the good fortune of sitting down with Tim Waterboer, PhD, leader of the Infections and Cancer Epidemiology Group at DKFZ, the German Cancer Research Center. Waterboer […]

Read More…

Adopting DigiWest®: How a Multiplex Immunoassay Is Making a Difference in Precision Oncology

Test replaced LDT, offering better ease of use and more comprehensive targets At CPO (Cellular Phenomics & Oncology), a Berlin-based company specializing in cellular phenomics and oncology, scientists are making significant progress in precision oncology by combining patient-derived, three-dimensional cell culture models with Luminex-based DigiWest® technology. The resulting data from this approach can inform the […]

Read More…

Tackling S. pneumoniae: Why Multiplexing Matters

Discriminating 93 serotypes takes a lot of beads Ger Rijkers and the Pneumococcal Consortium are working to develop standardized multiplex assays for S. pneumoniae antibodies. For this project, Rijkers, Head of the Department of Science at University College Roosevelt in The Netherlands, is designing a custom multiplex assay to efficiently identify the 93 antibodies against […]

Read More…

Partner Product Offerings: Millipore Sigma| Bio-Rad | R&D Systems|Thermo Fisher Scientific

There are currently more than 60 Luminex Licensed Technologies Partners worldwide that provide kits, assay development, and testing services for the research and diagnostic markets. While you can find more than 1,400 commercially available multiplex immunoassays in the xMAP® Kit Finder, below is a selection of the newest products and services. Millipore Sigma Bio-Rad R&D […]

Read More…

5 Tips for Multiplex Kit Users and Assay Developers

Woei Tan, PhD, is a Senior Staff Scientist at Bio-Rad Laboratories in the San Francisco Bay Area. Tan shares a few best practices that he’s learned while developing more than 400 Bio-Plex multiplex immunoassays over the past 15 years.   Plasma is processed from blood in the presence of an anticoagulant. Serum is processed from […]

Read More…

Meet Woei Tan: Master Multiplex Immunoassay Developer

Tan has developed more than 400 Bio-Plex® multiplex immunoassays Who are the people behind your multiplex immunoassay kits? Dr. Woei Tan is a Senior Staff Scientist at Bio-Rad Laboratories in the San Francisco Bay Area. He has developed more than 400 Bio-Plex® multiplex immunoassays over the past 15 years. When Woei isn’t at work, you’ll […]

Read More…

Delivering on the Promise of Personalized Medicine

Yoshihiko Fujita is discovering biomarkers to inform cancer treatment Yoshihiko Fujita is on the Faculty of Medicine in the Department of Genome Biology at Kindai University. Kindai University is the fourth largest comprehensive university in Japan. Dr. Fujita works in the laboratory of Kazuto Nishio, Chair of the Department of Genome Biology, who is renowned […]

Read More…